skye peptides retatrutide Reviews 2026: Reddit & COAs Retatrutide Dosing Guide for Researchers
Description
Pathogenesis of diabetic nephropathy
Retatrutide is an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors, currently unapproved by the MHRA, EMA, or FDA for routine clinical use
Tirzepatide is generally well tolerated, with mild gastrointestinal side effects
Clinically studied in ten trials and counting
The key difference is the end goal
